Clinical Trials Browser

Lymphoma, Multiple Myeloma

NCT04022980 2025-12-30

Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma

Phase 1 Completed

14 enrolled

Lymphoid

Lymphoma, Neurologic Manifestations

NCT03229278 2023-12-06

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Phase 1 Completed

14 enrolled 13 charts

DermatologicGenitourinaryHead & NeckLymphoidThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Lymphoma, Melanoma, Neoplasm Metastasis

NCT03580408 2022-08-19

Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients With Classical Hodgkin Lymphoma

Phase 2 Completed

64 enrolled

Lymphoid

Hodgkin Disease, Lymphoma

NCT03588936 2021-10-11

Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant

Phase 1 Terminated

2 enrolled

LymphoidMyeloid

Lymphoma, Myelodysplastic Syndromes

Clinical Trials

CPIT001

Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients With Classical Hodgkin Lymphoma

Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant